European Medicines Agency launches review of recalled heart drug

By |avgust 3rd, 2018|blood pressure, cancer, European Medicines Agency, NDMA, News, Zhejiang Huahai|

The European Medicines Agency (EMA) said Thursday it is conducting a review of the health effects on patients of a widely used blood pressure medication recalled around the world last month.